Boehringer Ingelheim Animal Health USA Inc v Elanco New Zealand
Patents – s 104 amendments – allowability of amendment excluding a compound not specifically mentioned in the specification prior to amendment but generally described – whether parties bound by findings made in substantive s 59 opposition